Literature DB >> 33015777

MiR-144 inhibits colorectal cancer cell migration and invasion by regulating PBX3.

B Cheng1, Y Zhang, Z-W Wu, Z-C Cui, W-L Li.   

Abstract

OBJECTIVE: MicroRNAs (miRNA) are aberrantly expressed in various human cancers, including colorectal cancer (CRC). We aim to investigate the functional role and underlying mechanism of miR-144 in CRC. PATIENTS AND METHODS: The expressional level of miR-144 and pre-leukemia transcription factor 3 (PBX3) in CRC tissues and cells was confirmed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot. The migration and invasion of CRC cells were detected by transwell assay. Luciferase reporter assay was performed to determine the specific target of miR-144 in CRC cells.
RESULTS: The results displayed that miR-144 expression was significantly decreased in CRC tissues and cells compared to that in normal controls. Additionally, miR-144 mimic suppressed, while miR-144 inhibitor promoted the ability of CRC cell migration and invasion. More importantly, PBX3 was the direct target of miR-144 in regulating CRC development and PBX3 could reverse the inhibitory effect of miR-144 mimic on CRC cells. PBX3 expression was significantly increased in CRC and negatively correlated with miR-144 expression.
CONCLUSIONS: In conclusion, miR-144 suppressed CRC cell migration and invasion by targeting PBX3, suggesting its potential value in the diagnosis and treatment of CRC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33015777     DOI: 10.26355/eurrev_202009_23019

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.

Authors:  Bin Han; Ke Xu; Dan Feng; Yang Bai; Yangqi Liu; Yuanyuan Zhang; Liming Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-27       Impact factor: 4.322

Review 2.  The regulation of PBXs and their emerging role in cancer.

Authors:  Ying Liu; Xiang Ao; Xuehao Zhou; Chengcheng Du; Shouxiang Kuang
Journal:  J Cell Mol Med       Date:  2022-01-23       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.